Seagen Inc. logo

Seagen Inc.

NASDAQ:SGEN

Overview | Financials
Company Name Seagen Inc.
Symbol SGEN
Currency USD
Price 228.74
Market Cap 43,154,776,450
Dividend Yield 0%
52-week-range 126.47 - 228.96
Industry Biotechnology
Sector Healthcare
CEO Mr. David R. Epstein B.Sc., M.B.A.
Website https://www.seagen.com

An error occurred while fetching data.

About Seagen Inc.

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced

Related Stocks

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

26 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

219.09 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

74.34 USD

Biogen Inc. logo

Biogen Inc.

BIIB

168.28 USD

Hologic, Inc. logo

Hologic, Inc.

HOLX

79.76 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

426.11 USD

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

212.27 USD

Financials

Numbers are in millions USD

Numbers are in millions USD